Literature DB >> 21304140

SPECT imaging of dopamine transporters with (99m)Tc-TRODAT-1 in major depression and Parkinson's disease.

Hao Wu1, Cen Lou, Zhongke Huang, Guohua Shi.   

Abstract

To investigate dopamine transporter in major depressive disorder and Parkinson's disease, the authors obtained single photon emission computed tomography (SPECT) brain images from 13 patients with major depression, 17 Parkinson's disease patients, and 10 healthy volunteers by using 99mTc-TRODAT-1. The authors found the 99mTc-TRODAT-1 radio signal in the striatum was reduced in the majority of patients with major depressive disorder, and this decrease was even more severe in patients with Parkinson's disease. The results support the hypothesis of dopamine hypofunction in major depressive disorder and suggest that deficient dopamine transporter may be involved in the etiology of severe major depressive disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21304140     DOI: 10.1176/jnp.23.1.jnp63

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  13 in total

1.  Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Daniela Di Giuda; Giovanni Camardese; Anna Rita Bentivoglio; Fabrizio Cocciolillo; Arianna Guidubaldi; Lorella Pucci; Isabella Bruno; Luigi Janiri; Alessandro Giordano; Alfonso Fasano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-14       Impact factor: 9.236

2.  Study on the executive function of attention in depression patients based on SPECT technology.

Authors:  Xiaoyi Li; Hao Wu; Cen Lou; Baoping Xing; Enyan Yu
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 3.  Systematic review of structural and functional neuroimaging findings in children and adults with CKD.

Authors:  Divya G Moodalbail; Kathryn A Reiser; John A Detre; Robert T Schultz; John D Herrington; Christos Davatzikos; Jimit J Doshi; Guray Erus; Hua-Shan Liu; Jerilynn Radcliffe; Susan L Furth; Stephen R Hooper
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-30       Impact factor: 8.237

Review 4.  Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders.

Authors:  Elizabeth K Nousen; Juliana G Franco; Elinor L Sullivan
Journal:  Neuroendocrinology       Date:  2013-09-21       Impact factor: 4.914

5.  Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective 123I-FP-CIT SPECT imaging genetic study.

Authors:  Sabine Hellwig; Lars Frings; Annette Masuch; Werner Vach; Katharina Domschke; Claus Normann; Philipp T Meyer
Journal:  J Neural Transm (Vienna)       Date:  2018-02-23       Impact factor: 3.575

6.  Optimization of imaging parameters for SPECT scans of [99mTc]TRODAT-1 using Taguchi analysis.

Authors:  Cheng-Kai Huang; Jay Wu; Kai-Yuan Cheng; Lung-Kwang Pan
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  Recent progress of imaging agents for Parkinson's disease.

Authors:  Xiaoai Wu; Huawei Cai; Ran Ge; Lin Li; Zhiyun Jia
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

8.  Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression.

Authors:  Juan Qiu; Sui-Yu Hu; Guang-Qing Shi; Su-E Wang
Journal:  Pharmacogn Mag       Date:  2014-10       Impact factor: 1.085

9.  Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies.

Authors:  Margaret T Davis; Sophie E Holmes; Robert H Pietrzak; Irina Esterlis
Journal:  Chronic Stress (Thousand Oaks)       Date:  2017-06-22

Review 10.  Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies.

Authors:  M-C Wen; L L Chan; L C S Tan; E K Tan
Journal:  Eur J Neurol       Date:  2016-06       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.